Cargando…

Biocompatibility and paclitaxel/cisplatin dual-loading of nanotubes prepared from poly(ethylene glycol)-polylactide-poly(ethylene glycol) triblock copolymers for combination cancer therapy

Nanotubes were prepared by self-assembly of the copolymer using co-solvent evaporation method. The biocompatibility of the nanotubes was assessed in comparison with spherical micelles and filomicelles prepared from poly(ethylene glycol)-poly(L-lactide-co-glycolide) (PEG-PLGA) and poly(ethylene glyco...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Xin, Wang, Yuandou, Xi, Laishun, Su, Feng, Li, Suming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978636/
https://www.ncbi.nlm.nih.gov/pubmed/31997910
http://dx.doi.org/10.1016/j.jsps.2019.08.005
_version_ 1783490740321517568
author Shen, Xin
Wang, Yuandou
Xi, Laishun
Su, Feng
Li, Suming
author_facet Shen, Xin
Wang, Yuandou
Xi, Laishun
Su, Feng
Li, Suming
author_sort Shen, Xin
collection PubMed
description Nanotubes were prepared by self-assembly of the copolymer using co-solvent evaporation method. The biocompatibility of the nanotubes was assessed in comparison with spherical micelles and filomicelles prepared from poly(ethylene glycol)-poly(L-lactide-co-glycolide) (PEG-PLGA) and poly(ethylene glycol)-poly(L-lactide) (PEG-PLA), respectively. Several aspects of biocompatibility of the aggregates were considered, including agar diffusion and MTT assay, release of cytokines, hemolysis, protein adsorption, dynamic clotting in vitro, and Zebrafish embryonic compatibility in vivo. The nanotubes present good cell compatibility and blood compatibility in vitro, and almost no toxicity towards Zebrafish embryos development in vivo. Furthermore, dual-loading of hydrophilic cisplatin and hydrophobic paclitaxel was achieved in the nanotubes with high loading content and loading efficiency. The release of both drugs was slower from dual-loaded nanotubes than from single-loaded ones, but the total amount of released drugs in higher for dual-loaded nanotubes than from single-loaded ones. Cellular uptake and inhibition tests showed that the nanotubes were successfully taken up by tumor cells and effectively inhibited cell growth. It is thus concluded that PEG-PLA-PEG nanotubes with outstanding biocompatibility could be promising for co-delivery of hydrophilic and hydrophobic agents in combination cancer therapy.
format Online
Article
Text
id pubmed-6978636
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-69786362020-01-29 Biocompatibility and paclitaxel/cisplatin dual-loading of nanotubes prepared from poly(ethylene glycol)-polylactide-poly(ethylene glycol) triblock copolymers for combination cancer therapy Shen, Xin Wang, Yuandou Xi, Laishun Su, Feng Li, Suming Saudi Pharm J Article Nanotubes were prepared by self-assembly of the copolymer using co-solvent evaporation method. The biocompatibility of the nanotubes was assessed in comparison with spherical micelles and filomicelles prepared from poly(ethylene glycol)-poly(L-lactide-co-glycolide) (PEG-PLGA) and poly(ethylene glycol)-poly(L-lactide) (PEG-PLA), respectively. Several aspects of biocompatibility of the aggregates were considered, including agar diffusion and MTT assay, release of cytokines, hemolysis, protein adsorption, dynamic clotting in vitro, and Zebrafish embryonic compatibility in vivo. The nanotubes present good cell compatibility and blood compatibility in vitro, and almost no toxicity towards Zebrafish embryos development in vivo. Furthermore, dual-loading of hydrophilic cisplatin and hydrophobic paclitaxel was achieved in the nanotubes with high loading content and loading efficiency. The release of both drugs was slower from dual-loaded nanotubes than from single-loaded ones, but the total amount of released drugs in higher for dual-loaded nanotubes than from single-loaded ones. Cellular uptake and inhibition tests showed that the nanotubes were successfully taken up by tumor cells and effectively inhibited cell growth. It is thus concluded that PEG-PLA-PEG nanotubes with outstanding biocompatibility could be promising for co-delivery of hydrophilic and hydrophobic agents in combination cancer therapy. Elsevier 2019-11 2019-08-30 /pmc/articles/PMC6978636/ /pubmed/31997910 http://dx.doi.org/10.1016/j.jsps.2019.08.005 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Shen, Xin
Wang, Yuandou
Xi, Laishun
Su, Feng
Li, Suming
Biocompatibility and paclitaxel/cisplatin dual-loading of nanotubes prepared from poly(ethylene glycol)-polylactide-poly(ethylene glycol) triblock copolymers for combination cancer therapy
title Biocompatibility and paclitaxel/cisplatin dual-loading of nanotubes prepared from poly(ethylene glycol)-polylactide-poly(ethylene glycol) triblock copolymers for combination cancer therapy
title_full Biocompatibility and paclitaxel/cisplatin dual-loading of nanotubes prepared from poly(ethylene glycol)-polylactide-poly(ethylene glycol) triblock copolymers for combination cancer therapy
title_fullStr Biocompatibility and paclitaxel/cisplatin dual-loading of nanotubes prepared from poly(ethylene glycol)-polylactide-poly(ethylene glycol) triblock copolymers for combination cancer therapy
title_full_unstemmed Biocompatibility and paclitaxel/cisplatin dual-loading of nanotubes prepared from poly(ethylene glycol)-polylactide-poly(ethylene glycol) triblock copolymers for combination cancer therapy
title_short Biocompatibility and paclitaxel/cisplatin dual-loading of nanotubes prepared from poly(ethylene glycol)-polylactide-poly(ethylene glycol) triblock copolymers for combination cancer therapy
title_sort biocompatibility and paclitaxel/cisplatin dual-loading of nanotubes prepared from poly(ethylene glycol)-polylactide-poly(ethylene glycol) triblock copolymers for combination cancer therapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978636/
https://www.ncbi.nlm.nih.gov/pubmed/31997910
http://dx.doi.org/10.1016/j.jsps.2019.08.005
work_keys_str_mv AT shenxin biocompatibilityandpaclitaxelcisplatindualloadingofnanotubespreparedfrompolyethyleneglycolpolylactidepolyethyleneglycoltriblockcopolymersforcombinationcancertherapy
AT wangyuandou biocompatibilityandpaclitaxelcisplatindualloadingofnanotubespreparedfrompolyethyleneglycolpolylactidepolyethyleneglycoltriblockcopolymersforcombinationcancertherapy
AT xilaishun biocompatibilityandpaclitaxelcisplatindualloadingofnanotubespreparedfrompolyethyleneglycolpolylactidepolyethyleneglycoltriblockcopolymersforcombinationcancertherapy
AT sufeng biocompatibilityandpaclitaxelcisplatindualloadingofnanotubespreparedfrompolyethyleneglycolpolylactidepolyethyleneglycoltriblockcopolymersforcombinationcancertherapy
AT lisuming biocompatibilityandpaclitaxelcisplatindualloadingofnanotubespreparedfrompolyethyleneglycolpolylactidepolyethyleneglycoltriblockcopolymersforcombinationcancertherapy